Eucrisa Ointment Dosing: Apply Approximately 3 mg/cm² Per Application
The FDA-approved dosing for Eucrisa (crisaborole) ointment is to "apply a thin layer twice daily to affected areas," without specifying an exact gram amount per dose, as the quantity varies based on the extent of body surface area involvement 1.
Practical Dosing Guidance Based on Clinical Studies
The actual amount used per application depends on the treatable body surface area (BSA):
Evidence from Pharmacokinetic Studies
Pediatric patients (ages 2-17 years) with mean BSA involvement of 49% (range 27-92%) applied approximately 6-30 grams per application at a dose of ~3 mg/cm² 1
Adolescents (ages 12-17 years) with 10-35% BSA involvement used dosing based on their baseline treatable BSA 2
The standard application technique is approximately 3 mg/cm² of affected skin 1, 3
Maximum Weekly Dosage Limit
Important safety consideration: Maximum of 60 grams should be applied per week (approximately 30 grams per application if used twice daily) to limit systemic absorption and reduce risk of serious adverse events 4.
Application Instructions
- Apply a thin layer to affected areas only
- Use twice daily initially until clinical effect is achieved
- Once controlled, consider reducing to once daily application 1
- For topical use only—not for ophthalmic, oral, or intravaginal use 1
Common Pitfalls to Avoid
- Over-application: Using more than a thin layer does not improve efficacy and increases systemic absorption risk
- Exceeding weekly maximum: Stay below 60 grams/week to minimize systemic exposure
- Treating non-affected areas: Apply only to active atopic dermatitis lesions, not normal skin
The lack of specific gram-per-dose guidance in the FDA label reflects the variable nature of atopic dermatitis presentation—dosing must be tailored to the actual extent of disease involvement while respecting the 60-gram weekly maximum 1.